Trial intelligence / Profile preview

Posaconazole PK in Children

NCT02358499Phase 1Completed

Sponsor
Children's Mercy Kansas City
Start
Jan 2015
Primary completion
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of posaconazole in fungal infection, sponsored by Children's Mercy Kansas City. Primary endpoints: Area under the plasma concentration versus time curve, Maximum Concentration and 2 more. Started Jan 2015; status: completed.

02

Drugs

posaconazole
03

Conditions

fungal infection

Beyond the preview

Go deeper on NCT02358499.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02358499.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call